Tomoyuki Nagata

1.0k total citations
56 papers, 789 citations indexed

About

Tomoyuki Nagata is a scholar working on Psychiatry and Mental health, Physiology and Cognitive Neuroscience. According to data from OpenAlex, Tomoyuki Nagata has authored 56 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Psychiatry and Mental health, 22 papers in Physiology and 12 papers in Cognitive Neuroscience. Recurrent topics in Tomoyuki Nagata's work include Dementia and Cognitive Impairment Research (28 papers), Alzheimer's disease research and treatments (21 papers) and Schizophrenia research and treatment (8 papers). Tomoyuki Nagata is often cited by papers focused on Dementia and Cognitive Impairment Research (28 papers), Alzheimer's disease research and treatments (21 papers) and Schizophrenia research and treatment (8 papers). Tomoyuki Nagata collaborates with scholars based in Japan, Canada and Estonia. Tomoyuki Nagata's co-authors include Shunichiro Shinagawa, Kazuhiko Nakayama, Hisashi Yamada, Nobuyuki Kobayashi, Kazuhiro Kondo, Kenji Tagai, Masahiro Shigeta, Shinichiro Nakajima, Masaru Mimura and Tohru Ohnuma and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Tomoyuki Nagata

52 papers receiving 778 citations

Peers

Countries citing papers authored by Tomoyuki Nagata

Since Specialization

Citations

This map shows the geographic impact of Tomoyuki Nagata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoyuki Nagata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoyuki Nagata more than expected).

Fields of papers citing papers by Tomoyuki Nagata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoyuki Nagata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoyuki Nagata. The network helps show where Tomoyuki Nagata may publish in the future.

Co-authorship network of co-authors of Tomoyuki Nagata

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoyuki Nagata. A scholar is included among the top collaborators of Tomoyuki Nagata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoyuki Nagata. Tomoyuki Nagata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Executive and General Cognitive Domain as a Relevant Factor of Specific Neuropsychiatric Symptoms in Alzheimer's Disease 2026 ·Geriatrics and gerontology international ·(unknown), Tomoyuki Nagata, (unknown), Shinsuke Kito, (unknown)	0
2	Alterations of neuropsychiatric symptoms in dementia patients during hospitalization in a dementia ward 2023 ·Psychogeriatrics ·Tomoyuki Nagata, Shunichiro Shinagawa, Nobuyuki Kobayashi, Kazuhiro Kondo, Masahiro Shigeta	0
3	Suppressors of Cytokine Signaling Are Decreased in Major Depressive Disorder Patients 2022 ·Journal of Personalized Medicine ·Nobuyuki Kobayashi, Shunichiro Shinagawa, Tomoyuki Nagata, Masahiro Shigeta, Kazuhiro Kondo	10
4	Clinicodemographic and Psychosocial Factors Related to Presentation or Severity of Delusions of Theft among Females with Amnestic Mild Cognitive Impairment and Alzheimer’s Disease 2020 ·Clinical Gerontologist ·(unknown), Shunichiro Shinagawa, (unknown), Tomoyuki Nagata, Kenji Tagai, (unknown), Masahiro Shigeta	1
5	Usefulness of DNA Methylation Levels in COASY and SPINT1 Gene Promoter Regions as Biomarkers in Diagnosis of Alzheimer’s Disease and Amnestic Mild Cognitive Impairment 2016 ·PLoS ONE ·Nobuyuki Kobayashi, Shunichiro Shinagawa, Tomoyuki Nagata, Kazuyuki Shimada, Nobuto Shibata, Tohru Ohnuma, Koji Kasanuki, Heii Arai, Hisashi Yamada, Kazuhiko Nakayama, Kazuhiro Kondo	24
6	Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer’s Disease and Amnesic Mild Cognitive Impairment 2016 ·PLoS ONE ·Nobuyuki Kobayashi, Shunichiro Shinagawa, Tomoyuki Nagata, Kazuyuki Shimada, Nobuto Shibata, Tohru Ohnuma, Koji Kasanuki, Heii Arai, Hisashi Yamada, Kazuhiko Nakayama, Kazuhiro Kondo	24
7	Executive Dysfunction Correlated With 2-Year Treatment Response in Patients With Late-Life Undifferentiated Somatoform Disorders 2016 ·Psychosomatics ·(unknown), Shunichiro Shinagawa, Tomoyuki Nagata, Kenji Tagai, (unknown), Kazuhiko Nakayama	3
8	Genetic Association between Presenilin 2 Polymorphisms and Alzheimer's Disease and Dementia of Lewy Body Type in a Japanese Population 2016 ·Dementia and Geriatric Cognitive Disorders Extra ·Ayako Suzuki, Nobuto Shibata, Koji Kasanuki, Tomoyuki Nagata, Shunichiro Shinagawa, Nobuyuki Kobayashi, Tohru Ohnuma, (unknown), Eri Kawai, (unknown), Kenya Nishioka, Yumiko Motoi, Nobutaka Hattori, Kazuhiko Nakayama, Hisashi Yamada, Heii Arai	3
9	Genetic Association Between KIBRA Polymorphism and Alzheimer’s Disease with in a Japanese Population 2015 ·NeuroMolecular Medicine ·Eri Kawai, Nobuto Shibata, Tomoyuki Nagata, Shunichiro Shinagawa, (unknown), Tohru Ohnuma, (unknown), (unknown), Koji Kasanuki, (unknown), Ayako Suzuki, Kazuhiko Nakayama, Hisashi Yamada, Heii Arai	9
10	White matter hyperintensities are associated with the severity of late-life somatoform disorders and executive functions 2015 ·Nordic Journal of Psychiatry ·(unknown), Shunichiro Shinagawa, Tomoyuki Nagata, Kenji Tagai, (unknown), Kazuhiko Nakayama	2
11	Age-Related Association between Apolipoprotein E ε4 and Cognitive Function in Japanese Patients with Alzheimer's Disease 2013 ·SHILAP Revista de lepidopterología ·Tomoyuki Nagata, Shunichiro Shinagawa, Bolati Kuerban, Nobuto Shibata, Tohru Ohnuma, Heii Arai, Kazuhiko Nakayama, Hisashi Yamada	2
12	Genetic association between APOA1 and APOD polymorphisms and Alzheimer’s disease in a Japanese population 2013 ·Journal of Neural Transmission ·Nobuto Shibata, Tomoyuki Nagata, Shunichiro Shinagawa, Tohru Ohnuma, (unknown), Miwa Komatsu, Bolati Kuerban, Katrin Tomson, Kazuhiko Nakayama, Hisashi Yamada, Heii Arai	14
13	Genetic Association between Neurotrophin-3 Polymorphisms and Alzheimer's Disease in Japanese Patients 2013 ·SHILAP Revista de lepidopterología ·Tomoyuki Nagata, Nobuto Shibata, Shunichiro Shinagawa, Ritsuko Nakayama, Bolati Kuerban, Tohru Ohnuma, Heii Arai, Kazuhiko Nakayama, Hisashi Yamada	7
14	Association between Neurotrophin-3 Polymorphisms and Executive Function in Japanese Patients with Amnestic Mild Cognitive Impairment and Mild Alzheimer Disease 2012 ·Dementia and Geriatric Cognitive Disorders ·Nobuyuki Kobayashi, Tomoyuki Nagata, Shunichiro Shinagawa, Ritsuko Nakayama, Kazuhiro Kondo, (unknown), Hisashi Yamada	7
15	Increase in the IgG avidity index due to herpes simplex virus type 1 reactivation and its relationship with cognitive function in amnestic mild cognitive impairment and Alzheimer’s disease 2012 ·Biochemical and Biophysical Research Communications ·Nobuyuki Kobayashi, Tomoyuki Nagata, Shunichiro Shinagawa, Naomi Oka, Kazuyuki Shimada, Akihiro Shimizu, Yoshitaka Tatebayashi, Hisashi Yamada, Kazuhiko Nakayama, Kazuhiro Kondo	59
16	A case in which mirtazapine reduced auditory hallucinations in a patient with Parkinson disease 2012 ·International Psychogeriatrics ·Tomoyuki Nagata, Shunichiro Shinagawa, Kenji Tagai, (unknown)	15
17	Association between brain‐derived neurotrophic factor (BDNF) gene polymorphisms and executive function in Japanese patients with Alzheimer's disease 2011 ·Psychogeriatrics ·Tomoyuki Nagata, Shunichiro Shinagawa, (unknown), (unknown), Satoshi Kawamura, (unknown), (unknown), Kazuhiko Nakayama, Hisashi Yamada	15
18	Association between Nerve Growth Factor Gene Polymorphism and Executive Dysfunction in Japanese Patients with Early-Stage Alzheimer’s Disease and Amnestic Mild Cognitive Impairment 2011 ·Dementia and Geriatric Cognitive Disorders ·Tomoyuki Nagata, Shunichiro Shinagawa, (unknown), Ritsuko Nakayama, Kazuhiko Nakayama, Hisashi Yamada	7
19	Correlation between a reduction in Frontal Assessment Battery scores and delusional thoughts in patients with Alzheimer's disease 2009 ·Psychiatry and Clinical Neurosciences ·Tomoyuki Nagata, Kazuhiro Ishii, Tatsuhiko Ito, (unknown), (unknown), (unknown), (unknown), Maki Tsumura, Shunichiro Shinagawa, (unknown), (unknown)	23
20	Effectiveness of carbamazepine for benzodiazepine‐resistant impulsive aggression in a patient with frontal infarctions 2007 ·Psychiatry and Clinical Neurosciences ·Tomoyuki Nagata, Daisuke Harada, (unknown), (unknown), (unknown), (unknown), Kazuhiko Nakayama	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact